Compound mutant mice using aP2-Cre to drive recombination resulting in biallelic Dicer1 deletion or the combination of oncogenic KrasG12D activation and Cdkn2a deletion result in angiosarcoma from the transformation of endothelial cells20,41. This evidence concerns the gene CDKN2A and angiosarcoma.